Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Morgan Stanley Maintains Equal-Weight on Lineage, Lowers Price Target to $46

Author: Benzinga Newsdesk | September 22, 2025 01:34pm
Morgan Stanley analyst Ronald Kamdem maintains Lineage (NASDAQ:LINE) with a Equal-Weight and lowers the price target from $50 to $46.

Posted In: LINE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist